Roy Zou > Hogan Lovells International LLP > Beijing, China > Lawyer Profile

Hogan Lovells International LLP
31st Floor, Tower 3, China Central Place
No. 77 Jianguo Road, Chaoyang District
Beijing 100025
China
Roy Zou photo

Work Department

Corporate

Position

Office Managing Partner

Career

Roy Zou works with companies on merger and acquisition transactions, the creation of joint ventures, market entry, and international trade. He has in-depth experience in directing legal and financial due diligence reviews of Chinese companies for multinational corporations and investors. Over the decades, Roy regularly dealt with approval authorities and other government regulators and agencies in connection with commercial transactions. Roy also worked on a number of U.S. litigations involving Chinese companies or government agencies as respondents or defendants. His career has spanned corporate, government, and regulatory practices. He has vast experience on export control, sanction, cybersecurity, and data protection issues.

Roy previously worked at the Ministry of Foreign Affairs of the People’s Republic of China for seven years. Serving in the General Office and the Department of Treaty and Law, he was involved in the documentation and negotiation of many important bilateral and multilateral issues. Roy’s diplomatic career included assignments in overseas Chinese missions. Roy speaks Mandarin and English.

Languages

English, Mandarin

Education

LL.M. Program, Duke University, 1998

LL.M., Legal Institute of the China Academy, 1997

B.A., Wuhan University, 1987

Lawyer Rankings

China > Life sciences and healthcare: foreign firms

Offering expertise on regulatory compliance, M&A deals in the life sciences space, sanctions and export controls, and the legal implications of clinical trials, Hogan Lovells International LLP provides a comprehensive service for clients in the Chinese market. The team is jointly led by Roy Zou, who is highly experienced in U.S. litigation matters involving Chinese companies or government agencies as respondents or defendants, and cross-border transactional and financing expert Lu Zhou. The regulatory compliance focussed Calvin Ding, who is experienced in both government sanctioned and internal compliance investigations, is also key, as is life sciences and healthcare sector antitrust expert Adrian Emch. Jessie Xie, who specialises in medical device and pharmaceutical clinical trials and product approval issues, is also well-recommended.